annb0t
Top 20
Haemonetics HAE continues to expand its business, banking on growth drivers like Plasma, Thromboelastography (TEG), Hemostasis Management and the Vascular Closure business. The stock sports a Zacks Rank #1 (Strong Buy).
Haemoneticsâ Plasma business unit focuses on the collection of source plasma for pharmaceutical manufacturers using apheresis devices that only collect plasma. The demand for source plasma has continued to grow due to an expanding end-user market for plasma-derived biopharm...
>>> Read more: Haemonetics' (HAE) Hospital & Plasma Segments, Innovation Aid
Haemoneticsâ Plasma business unit focuses on the collection of source plasma for pharmaceutical manufacturers using apheresis devices that only collect plasma. The demand for source plasma has continued to grow due to an expanding end-user market for plasma-derived biopharm...
>>> Read more: Haemonetics' (HAE) Hospital & Plasma Segments, Innovation Aid
